Kegiatan Pemeriksaan Kadar Kolesterol pada Petugas dan Karyawan SMA Santo Yoseph, Cakung
DOI:
https://doi.org/10.58192/karunia.v3i4.2660Keywords:
Education, occupational health, cholesterol, routine screening, preventionAbstract
Cholesterol is a lipid compound produced by the body and obtained from food, functioning to build cell membranes, produce certain hormones, and support metabolic processes in the body. Excessive cholesterol levels can increase the risk of cardiovascular diseases. This Community Service initiative aims to enhance the understanding and awareness of staff and employees at St. Yoseph High School, Cakung, regarding the risks of high cholesterol and preventive measures through routine screenings and health education. The program follows the Plan-Do-Check-Act (PDCA) approach, encompassing planning for education and screenings, conducting information sessions and cholesterol measurements, evaluating program effectiveness, and implementing follow-up actions for continuous improvement. Education on a healthy lifestyle, which includes a balanced diet, physical activity, and avoidance of alcohol and smoking, plays a vital role in maintaining normal cholesterol levels. Routine screenings are also essential for the early detection of high cholesterol risks. This initiative is expected to promote healthy behaviors and support improved workplace health by raising awareness about the importance of cholesterol prevention in the work environment.
References
Barter, P. J., Ballantyne, C. M., Carmena, R., Cabezas, M. C., Chapman, M. J., Couture, P., Graaf, J. de, Durrington, P. N., Færgeman, O., Fröhlich, J., Furberg, C. D., Gagné, C., Haffner, S. M., Humphries, S. E., Jungner, I., Krauss, R. M., Kwiterovich, P. O., Marcovina, S. M., Packard, C. J., … Williams, K. (2006). Apo B Versus Cholesterol in Estimating Cardiovascular Risk and in Guiding Therapy: Report of the Thirty‐person/Ten‐country Panel. Journal of Internal Medicine, 259(3), 247–258. https://doi.org/10.1111/j.1365-2796.2006.01616.x
Corral, P., Aguilar Salinas, C. A., Matta, M. G., Zago, V., & Schreier, L. (2023). Stratification in Heterozygous Familial Hypercholesterolemia: Imaging, Biomarkers, and Genetic Testing. Current Atherosclerosis Reports, 25(12), 899–909. https://doi.org/10.1007/s11883-023-01160-9
Emelyanchik, V. S., Никулина, С. Ю., Emelyanchik, E. Y., & Protopopov, A. V. (2023). New Opportunities for Identifying the Risk of Cardiovascular Events in Young People: The Role of Familial Hypercholesterolemia. Russian Journal of Cardiology, 27(12), 5294. https://doi.org/10.15829/1560-4071-2022-5294
Ernawati, E., Adjie, E. K. K., Firmansyah, Y., Yogie, G. S., Setyanegara, W. G., & Kurniawan, J. (2023). Pengaruh Kadar Profil Lipid, Asam Urat, Indeks Massa Tubuh, Tekanan Darah, dan Kadar Gula Darah Terhadap Penurunan Kapasitas Vital Paru pada Pekerja Usia Produktif. Malahayati Nursing Journal. https://api.semanticscholar.org/CorpusID:260389865
Firmansyah, Y., Averina, F., & Audrey, L. (2024). Program Pengabdian Masyarakat Melalui Edukasi Dan Skrining Profil Lipid Serta Hubungannya Dengan Perlemakan Hati Pada Komunitas Lansia. Karunia: Jurnal Hasil Pengabdian Masyarakat Indonesia, 3(2), 90–98.
Girardi, J. M., & Couto, A. A. Do. (2023). Role of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance. Archives of Health, 4(1), 108–119. https://doi.org/10.46919/archv4n1-011
Gu, P.-S., Su, K., Yeh, K., Huang, J., Lo, F., & Chiu, C. (2023). Metabolomics Analysis Reveals Molecular Signatures of Metabolic Complexity in Children With Hypercholesterolemia. Nutrients, 15(7), 1726. https://doi.org/10.3390/nu15071726
Jin, M., Meng, F., Yang, W., Liang, L., Wang, H., & Zhenyan, F. U. (2021). Efficacy and Safety of Evinacumab for the Treatment of Hypercholesterolemia: A Meta-Analysis. Journal of Cardiovascular Pharmacology, 78(3), 394–402. https://doi.org/10.1097/fjc.0000000000001073
Klop, B., Elte, J. W. F., & Cabezas, M. C. (2013). Dyslipidemia in obesity: mechanisms and potential targets. Nutrients, 5(4), 1218–1240. https://doi.org/10.3390/nu5041218
Li, N., Li, Q., Tian, X., Qian, H.-Y., & Yang, Y. (2014). Mipomersen Is a Promising Therapy in the Management of Hypercholesterolemia: A Meta-Analysis of Randomized Controlled Trials. American Journal of Cardiovascular Drugs, 14(5), 367–376. https://doi.org/10.1007/s40256-014-0077-0
Li, Y. H., Ueng, K. C., Jeng, J. S., Charng, M. J., Lin, T. H., Chien, K. L., Wang, C. Y., Chao, T. H., Liu, P. Y., Su, C. H., Chien, S. C., Liou, C. W., Tang, S. C., Lee, C. C., Yu, T. Y., Chen, J. W., Wu, C. C., & Yeh, H. I. (2017). 2017 Taiwan lipid guidelines for high risk patients. Journal of the Formosan Medical Association, 116(4), 217–248. https://doi.org/10.1016/j.jfma.2016.11.013
Maccubbin, D., Bays, H., Olsson, A., Elinoff, V., Elis, A., Mitchel, Y., Sirah, W., Betteridge, A., Reyes, R., Yu, Q., Kuznetsova, O. M., Sisk, C. M., Pasternak, R. C., & Paolini, J. F. (2008). Lipid-Modifying Efficacy and Tolerability of Extended-Release Niacin/Laropiprant in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia. International Journal of Clinical Practice, 62(12), 1959–1970. https://doi.org/10.1111/j.1742-1241.2008.01938.x
Maștaleru, A., Cojocariu, S. A., Oancea, A., Leon‐Constantin, M., Roca, M., Zota, I. M., Abdulan, I. M., Rusu, C., Popescu, R., Antoci, L. M., Ciobanu, C. G., Costache, A. D., Cojocaru, E., & Mitu, F. (2022). Genetic Polymorphisms in a Familial Hypercholesterolemia Population From North-Eastern Europe. Journal of Personalized Medicine, 12(3), 429. https://doi.org/10.3390/jpm12030429
Radyaputri, A. (2024). The Relationship of Apolipoprotein B and Major Adverse Cardiovascular Events (MACE) in Patients with Coronary Heart Disease as a Prognostic Factor: A Literature Review. SCRIPTA SCORE Scientific Medical Journal, 5(2), 165–170. https://doi.org/10.32734/scripta.v5i2.15234
Rosei, E. A., & Salvetti, M. (2016). Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients With High Cardiovascular Risk. High Blood Pressure & Cardiovascular Prevention, 23(3), 217–230. https://doi.org/10.1007/s40292-016-0155-2
Ruslim, W. H., Santoso, A. H., Kurniawan, J., Destra, E., Setiawan, F. V., & Wijaya, B. A. (2024). Peningkatan Kewaspadaan terhadap Hiperlipidemia Melalui Pemeriksaan Kadar Kolesterol pada Kelompok Lanjut Usia di Panti Werda Hana. Jurnal Pelayanan Dan Pengabdian Masyarakat Indonesia, 3(2), 1–6.
Tokgözoğlu, L., & Kayıkçıoğlu, M. (2021). Familial Hypercholesterolemia: Global Burden and Approaches. Current Cardiology Reports, 23(10). https://doi.org/10.1007/s11886-021-01565-5
Tomlinson, B., Chan, P., Zhang, Y., & Liu, Z. (2020). Pharmacokinetics of Current and Emerging Treatments for Hypercholesterolemia. Expert Opinion on Drug Metabolism & Toxicology, 16(5), 371–385. https://doi.org/10.1080/17425255.2020.1749261
Warden, B. A., & Duell, P. B. (2021). Evinacumab for Treatment of Familial Hypercholesterolemia. Expert Review of Cardiovascular Therapy, 19(8), 739–751. https://doi.org/10.1080/14779072.2021.1955349
